Overview
One Drop is a health tech platform that helps people manage diabetes and other health conditions. Its main product is a mobile app that syncs with a Bluetooth-enabled blood glucose meter to track readings and related metrics such as blood pressure, heart health, and weight. Users subscribe to bundles that include test strips, lancets, and personalized coaching, with options like Complete Diabetes or Complete Weight for Heart Health, plus a One Drop Premium membership. The platform integrates with other health apps and devices to consolidate data and provide ongoing coaching for proactive wellness.
Work here?Claim your company
Simplify's take
What believers are saying
- MannKind started the A-ONE trial on November 7, 2026, pairing Afrezza with One Drop.
- Bayer's AI heart-disease module signals recurring enterprise monetization beyond consumer subscriptions.
- One Drop reports over 100 million data points and 2 million logins.
What critics are saying
- Fitbit and Bayer control distribution and roadmap leverage over One Drop.
- Dexcom and Abbott own glucose sensing hardware, squeezing One Drop's meter and strip economics.
- Apple HealthKit, Fitbit, and Bayer can absorb One Drop into commodity features.
What makes One Drop unique
- One Drop Chrome won US and EU approval on November 6, 2026.
- Its app fuses glucose, meals, medication, activity, and coaching into one workflow.
- Fitbit, Apple HealthKit, and MyFitnessPal integrations create unusually dense lifestyle data.
Help us improve and share your feedback! Did you find this helpful?
Funding
Notable Investors:
Series C funding is usually for startups that are doing well and are looking for more money to fuel major growth, such as acquiring other companies, expanding into global markets, or launching new product lines. Investors typically include larger venture capital firms and private equity.
Series C Funding Comparison
Industry standards
Ind Avg. $50M
$16M
$34.7M
$40M
$50M
$62M
$100M